The Carlyle Group Inc. (CG) Competitors & Peers
The 5 largest companies in the same industry as The Carlyle Group Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| BLK | Peer | $1,069.78 | P/E 25.2RSI 38Cap 163.0 B |
| BX | Peer | $124.96 | P/E 27.8RSI 35Cap 93.0 B |
| BN | Peer | $37.51 | P/E 68.7RSI 24Cap 82.8 B |
| KKR | Competitor | $98.81 | P/E 31.8RSI 39Cap 89.4 B |
| BAM | Peer | $46.06 | P/E 26.4RSI 35Cap 73.4 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- KKRCompetitor
Top PE shops.
Model-inferred, unverified — treat as a lead, not evidence - BAXSupplier
Carlyle acquired Vantive (Baxter Kidney Care) for $3.8B.
Model-inferred, unverified — treat as a lead, not evidence - APOCompetitor
Top PE shops.
Model-inferred, unverified — treat as a lead, not evidence